Blumenkranz Mark S. 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-24 2:27 pm Purchase |
2021-11-15 | 13D | Kala Pharmaceuticals, Inc. KALA |
Blumenkranz Mark S. | 213,645 7.300% |
213,645 (New Position) |
Filing |